Turnaround time
10 workdays
48.4
40
DNA test for the SLC25A12 c.1337C>T variant causing CDMC in Nova Scotia Duck Tolling Retrievers.
Overview
This genetic test analyses the SLC25A12 c.1337C>T variant in the Nova Scotia Duck Tolling Retriever. The disorder is described as cerebellar degeneration-myositis complex, abbreviated CDMC.
CDMC is a severe degenerative neuromuscular disorder involving both the cerebellum and muscles. Affected puppies may develop ataxia, head tremors, hypermetria, generalized weakness, exercise intolerance, stiffness, collapse episodes and bunny-hopping from about 10 weeks to 6 months of age. The disorder can be severe and is important for breeding plans within the breed.
The trait is autosomal recessive. C/C means clear, C/T means carrier and T/T causes the genetic form of SLC25A12-related CDMC.
Included subanalyses
This analysis includes the following subanalysis:
Allele combinations & result interpretations
Below, for each tested locus, you will find the possible allele combinations that may be reported within this analysis, together with a brief explanation of their genetic meaning. The interpretation of possible interactions between different loci is included in the report, but is not shown here in full because that would lead to too many combinations on this page. The final expression may also depend on other genes and their interaction.
Genotype / allele combination: C/C - no CDMC variant detected
The dog does not carry the tested SLC25A12 c.1337C>T variant and will not pass this variant to offspring.
Genotype / allele combination: C/T - CDMC carrier
The dog carries one copy of the CDMC variant. The dog is not genetically affected for this recessive test, but can pass the variant to about half of its offspring. Avoid matings with another carrier.
Genotype / allele combination: T/T - affected genotype for CDMC
The dog has two copies of the CDMC variant. This genotype causes SLC25A12-gerelateerde cerebellar degeneration-myositis complex / CDMC and explains a high risk of the described neurological disorder.
Sampling and submission guidelines





References